Myeloma: Update on supportive care strategies (Q35116240)

6 August 2017

1 reference

title

Myeloma: update on supportive care strategies (English)

1 reference

6 August 2017

Myeloma: Update on supportive care strategies (English)

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

28 December 2023

2

Ramón García-Sanz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12718802

28 December 2023

author name string

Jesús F. San Miguel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12718802

28 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12718802

28 December 2023

publication date

1 June 2003

1 reference

full work available at URL

6 August 2017

https://link.springer.com/content/pdf/10.1007/s11864-003-0026-7.pdf

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

https://link.springer.com/article/10.1007/s11864-003-0026-7/fulltext.html

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

http://link.springer.com/content/pdf/10.1007/s11864-003-0026-7

28 December 2023

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

Current Treatment Options in Oncology

28 December 2023

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

247-258

1 reference

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

Negative regulation of erythroblast maturation by Fas-L( )/TRAIL( ) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

21 January 2018

1 reference

12 December 2020

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma

1 reference

12 December 2020

An evidence-based evaluation of percutaneous vertebroplasty

1 reference

12 December 2020

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

12 December 2020

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

12 December 2020

Invasive Aspergillosis as an Opportunistic Infection in Nonallografted Patients with Multiple Myeloma: A European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

1 reference

12 December 2020

Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients

1 reference

12 December 2020

Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)

1 reference

12 December 2020

Renal Failure in Multiple Myeloma

1 reference

12 December 2020

Prophylactic antibiotics for the prevention of early infection in multiple myeloma

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia

1 reference

12 December 2020

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma

1 reference

12 December 2020

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

1 reference

12 December 2020

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

1 reference

12 December 2020

Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect

1 reference

12 December 2020

Treatment of multiple myeloma

1 reference

12 December 2020

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy

1 reference

12 December 2020

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.

1 reference

12 December 2020

Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

1 reference

12 December 2020

Effect of daily etidronate on the osteolysis of multiple myeloma

1 reference

12 December 2020

Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma

1 reference

12 December 2020

Development and characterization of novel erythropoiesis stimulating protein (NESP)

1 reference

12 December 2020

Complications of bone metastases: surgical management

1 reference

12 December 2020

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

1 reference

12 December 2020

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

12 December 2020

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

1 reference

12 December 2020

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

12 December 2020

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

1 reference

12 December 2020

Use of recombinant human erythropoietin outside the setting of uremia

1 reference

12 December 2020

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

12 December 2020

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

1 reference

12 December 2020

Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations

1 reference

12 December 2020

Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma

1 reference

12 December 2020

Renal failure in multiple myeloma. Pathogenesis and prognostic implications

1 reference

12 December 2020

Immunological factors and risk of infection in plateau phase myeloma

1 reference

12 December 2020

Immunization of transplant recipients

1 reference

12 December 2020

Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone

1 reference

12 December 2020

Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma

1 reference

12 December 2020

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and N

1 reference

12 December 2020

1

84

36

Miguel JF San

1999

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

The European journal of medicine

28 December 2023

42

2

449

A Daragon

1993

1 reference

https://api.crossref.org/works/10.1007/S11864-003-0026-7

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference